Limited Sampling Strategy for Mycophenolic Acid in Chinese Kidney Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus During the Early Posttransplantation Phase
Xi Yao,Hongfeng Huang,Chunchun Wei,Ying Chen,Wenhan Peng,Wenqing Xie,Jianghua Chen
DOI: https://doi.org/10.1097/ftd.0000000000000170
2015-01-01
Therapeutic Drug Monitoring
Abstract:Background:Mycophenolic acid (MPA), a potent immunosuppressant, is widely used in solid organ transplantations. This study aimed to investigate the pharmacokinetics of enteric-coated mycophenolate sodium (EC-MPS) in Chinese adult renal allograft recipients and to generate optimal model equations for estimation of the MPA area under the concentration-time curve from 0 to 12 hours (AUC(0-12 h)), using a limited sampling strategy (LSS).Methods:Serial blood samples were collected over 12 hours from 38 recipients of a primary living-related donor kidney graft treated with EC-MPS, tacrolimus, and corticosteroid. MPA concentrations were evaluated using an enzyme-multiplied immunoassay technique. The LSSs were developed and validated by multiple regression analysis using a 2-group method (test group, n = 19; validation group, n = 19).Results:The best algorithms obtained from the test group were the following: 15.09 + 1.05 x C-1.5 + 1.8 x C-4 + 4.18 x C-6 (for 3 time points, r(2) = 0.902) and 10.44 + 0.7 x C-1 + 1.22 x C-2 + 1.75 x C-4 + 4.36 x C-6 (for 4 time points, r(2) = 0.941). When these algorithms were tested in the validation group, there were no significant differences in prediction errors.Conclusions:LSSs using time points of 1.5, 4, and 6 hours or 1, 2, 4, and 6 hours after dose provide effective and reliable estimations of the MPA AUC(0-12 h) in Chinese renal allograft recipients treated concomitantly with EC-MPS and tacrolimus during the early posttransplantation phase.